FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121380498> ?p ?o ?g. }

• W2121380498 abstract "Venous leg ulcers are common, chronic wounds caused by venous diseases, with a high recurrence rate and heavy disease burden. Compression therapy (bandages or stockings) is the first choice treatment for venous leg ulcers. However, when ulcers remain unhealed, medication can also be used with or without compression therapy. Sulodexide, a highly purified glycosaminoglycan (a naturally occurring molecule) has antithrombotic and profibrinolytic properties (it reduces the formation of blood clots) as well as anti-inflammatory effects. Sulodexide has been studied as a potential treatment for venous leg ulcers.To assess the efficacy and safety of sulodexide for treating venous leg ulcers.In July 2015 we searched: The Cochrane Wounds Specialised Register; The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library); Ovid MEDLINE; Ovid MEDLINE (In-Process & Other Non-Indexed Citations); Ovid EMBASE; EBSCO CINAHL; Chinese Biomedical Literature Database (CBM); China National Knowledge Infrastructure Database (CNKI); Wan Fang and VIP. We also searched clinical trials registries to identify ongoing studies, as well as references listed in relevant publications. There were no restrictions based on date of publication, language or study setting.Randomised controlled trials (RCTs) involving people with a diagnosis of venous leg ulcers which compared sulodexide with placebo or any other drug therapy (such as pentoxifylline, flavonoids, aspirin), with or without compression therapy.We used standard Cochrane methodological procedures. The authors independently selected studies, extracted data and assessed risk of bias. We pooled data to present the risk ratio (RR) with 95% confidence interval (CI), or presented a narrative summary. We assessed overall evidence quality according to the GRADE approach.We included four RCTs with a total of 463 participants (aged 42 years to 93 years); one report was only available as a published abstract.Meta-analysis of three RCTs suggests an increase in the proportion of ulcers completely healed with sulodexide as an adjuvant to local treatment (including wound care and compression therapy) compared with local treatment alone (rate of complete healing with sulodexide 49.4% compared with 29.8% with local treatment alone; RR 1.66; 95% CI 1.30 to 2.12). This evidence for sulodexide increasing the rate of complete healing is low quality due to risk of bias. It is unclear whether sulodexide is associated with any increase in adverse events (4.4% with sulodexide versus 3.1% with no sulodexide; RR 1.44; 95% CI 0.48 to 4.34). The evidence for adverse events is very low quality, downgraded twice for risk of bias and once for imprecision.Sulodexide may increase the healing of venous ulcers, when used alongside local wound care, however the evidence is only low quality and the conclusion is likely to be affected by new research. It is not clear whether sulodexide is associated with adverse effects. The standard dosage, route and frequency of sulodexide reported in the trials was unclear. Further rigorous, adequately powered RCTs examining the effects of sulodexide on healing, ulcer recurrence, quality of life and costs are necessary." @default.
• W2121380498 created "2016-06-24" @default.
• W2121380498 creator A5004605892 @default.
• W2121380498 creator A5007812706 @default.
• W2121380498 creator A5023307603 @default.
• W2121380498 creator A5089420346 @default.
• W2121380498 date "2016-06-02" @default.
• W2121380498 modified "2023-09-23" @default.
• W2121380498 title "Sulodexide for treating venous leg ulcers" @default.
• W2121380498 cites W122071364 @default.
• W2121380498 cites W1493239945 @default.
• W2121380498 cites W1496722696 @default.
• W2121380498 cites W1502961603 @default.
• W2121380498 cites W1800544167 @default.
• W2121380498 cites W1820820441 @default.
• W2121380498 cites W1835719993 @default.
• W2121380498 cites W1877853587 @default.
• W2121380498 cites W1892390879 @default.
• W2121380498 cites W1906890694 @default.
• W2121380498 cites W1919519471 @default.
• W2121380498 cites W1930266813 @default.
• W2121380498 cites W1967893066 @default.
• W2121380498 cites W1977131443 @default.
• W2121380498 cites W1979586498 @default.
• W2121380498 cites W1983845869 @default.
• W2121380498 cites W1984890126 @default.
• W2121380498 cites W1984900730 @default.
• W2121380498 cites W1990166011 @default.
• W2121380498 cites W1999421223 @default.
• W2121380498 cites W2011214843 @default.
• W2121380498 cites W2030216911 @default.
• W2121380498 cites W2032274203 @default.
• W2121380498 cites W2033115031 @default.
• W2121380498 cites W2033996199 @default.
• W2121380498 cites W2036484524 @default.
• W2121380498 cites W2041400912 @default.
• W2121380498 cites W2071782474 @default.
• W2121380498 cites W2071994038 @default.
• W2121380498 cites W2074327900 @default.
• W2121380498 cites W2100272811 @default.
• W2121380498 cites W2120596253 @default.
• W2121380498 cites W2125435699 @default.
• W2121380498 cites W2128899119 @default.
• W2121380498 cites W2130035979 @default.
• W2121380498 cites W2135635656 @default.
• W2121380498 cites W2136952864 @default.
• W2121380498 cites W2155109939 @default.
• W2121380498 cites W2160831490 @default.
• W2121380498 cites W2164500209 @default.
• W2121380498 cites W2179229753 @default.
• W2121380498 cites W2235523863 @default.
• W2121380498 cites W2568771235 @default.
• W2121380498 cites W3022903699 @default.
• W2121380498 cites W48086030 @default.
• W2121380498 doi "https://doi.org/10.1002/14651858.cd010694.pub2" @default.
• W2121380498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27251175" @default.
• W2121380498 hasPublicationYear "2016" @default.
• W2121380498 type Work @default.
• W2121380498 sameAs 2121380498 @default.
• W2121380498 citedByCount "17" @default.
• W2121380498 countsByYear W21213804982016 @default.
• W2121380498 countsByYear W21213804982017 @default.
• W2121380498 countsByYear W21213804982018 @default.
• W2121380498 countsByYear W21213804982019 @default.
• W2121380498 countsByYear W21213804982020 @default.
• W2121380498 countsByYear W21213804982022 @default.
• W2121380498 countsByYear W21213804982023 @default.
• W2121380498 crossrefType "journal-article" @default.
• W2121380498 hasAuthorship W2121380498A5004605892 @default.
• W2121380498 hasAuthorship W2121380498A5007812706 @default.
• W2121380498 hasAuthorship W2121380498A5023307603 @default.
• W2121380498 hasAuthorship W2121380498A5089420346 @default.
• W2121380498 hasBestOaLocation W21213804982 @default.
• W2121380498 hasConcept C118552586 @default.
• W2121380498 hasConcept C126322002 @default.
• W2121380498 hasConcept C141071460 @default.
• W2121380498 hasConcept C142724271 @default.
• W2121380498 hasConcept C168563851 @default.
• W2121380498 hasConcept C17744445 @default.
• W2121380498 hasConcept C1862650 @default.
• W2121380498 hasConcept C199539241 @default.
• W2121380498 hasConcept C204787440 @default.
• W2121380498 hasConcept C27081682 @default.
• W2121380498 hasConcept C27415008 @default.
• W2121380498 hasConcept C2776478404 @default.
• W2121380498 hasConcept C2777628954 @default.
• W2121380498 hasConcept C2779473830 @default.
• W2121380498 hasConcept C2781145037 @default.
• W2121380498 hasConcept C44249647 @default.
• W2121380498 hasConcept C71924100 @default.
• W2121380498 hasConcept C82789193 @default.
• W2121380498 hasConcept C95190672 @default.
• W2121380498 hasConceptScore W2121380498C118552586 @default.
• W2121380498 hasConceptScore W2121380498C126322002 @default.
• W2121380498 hasConceptScore W2121380498C141071460 @default.
• W2121380498 hasConceptScore W2121380498C142724271 @default.
• W2121380498 hasConceptScore W2121380498C168563851 @default.
• W2121380498 hasConceptScore W2121380498C17744445 @default.
• W2121380498 hasConceptScore W2121380498C1862650 @default.
• W2121380498 hasConceptScore W2121380498C199539241 @default.

• next